Evidence map›Paper›PMID 36006458›Full record

ArticleRheumatology international2022

Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.

Yusuf Karabulut, Nuran Öz, Halise Hande Gezer, İrfan Esen, Mehmet Tuncay Duruöz

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Rheumatic Manifestations of Sarcoidosis.Diagnostics (Basel, Switzerland) · 2024
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yusuf KarabulutDepartment of Internal Medicine, Division of Rheumatology, Yıldırım Doruk Hospital, Bursa, Turkey. yusufkarabulut.dr@gmail.com.ORCID 0000-0003-2690-6196
Nuran ÖzDepartment of Physical Medicine and Rehabilitation, Division of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey.ORCID 0000-0002-1002-962X
Halise Hande GezerDepartment of Rheumatology, Ümraniye Training and Research Hospital, Istanbul, Turkey.ORCID 0000-0001-8790-304X
İrfan EsenDepartment of Internal Medicine. Division of Oncology, Ankara Şehir Hospital, Ankara, Turkey.ORCID 0000-0002-7063-6309
Mehmet Tuncay DuruözDepartment of Physical Medicine and Rehabilitation, Division of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey.ORCID 0000-0003-3584-2788
Marmara University · TRBursa Yuksek Ihtisas Egitim Ve Arastirma Hastanesi · TRÜmraniye Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis may present with many rheumatological symptoms as well as mimic and/or may occur concomitantly with many other rheumatic diseases. We examined the demographic, clinical and laboratory characteristics of patients diagnosed with sarcoidosis in the rheumatology department. This study planned as retrospective cross-sectional study. Medical records of patients who applied to our rheumatology outpatient clinic due to complain of musculoskeletal problems and then diagnosed sarcoidosis were retrospectively investigated. Joint findings, extrapulmonary involvements, and coexisting rheumatic disease were evaluated. Fifty-six patients (41.21 ± 7.83 years, 75% female) were included. The duration of the disease was 49.61 ± 29.11 months, and the follow-up period was 26.66 ± 13.26 months. All patients had pulmonary system involvement. Arthralgia was present in 91.10% of 56 patients and arthritis in 89.29% of patients. Examining the subtypes of the arthritis findings, mono-arthritis was found in 31/50 (62%) patients, oligo-arthritis in 15/50 (30%) patients, and polyarthritis in 4/50 (8%) patients. A total of 11 (19.60%) patients were diagnosed with uveitis. Excision of the mediastinal LAP was performed in a total of 37 patients (66.1%) and became the most commonly employed method. Considering the treatment distribution of the patients under followed-up, it is seen that non-steroidal anti-inflammatory treatments were used in 15 (26.8%) patients, corticosteroids in a total of 40 (71.4%) patients, methotrexate in a total of 15 patients (26.8%), azathioprine in six (10.7%) patients, hydroxychloroquine in 14 (25%) patients, and infliximab in one (1.8%) patient. As sarcoidosis is a mimicking disease, a good differential diagnosis should be made to avoid misdiagnosis and in order not to be late in diagnosis and treatment. Physicians, especially rheumatologists, should remember sarcoidosis more frequently as the disease may overlap with other rheumatological diseases and may occur with many rheumatological manifestations.

Indexed as

ArthritisRheumatic DiseasesRheumatologySarcoidosisAdrenal Cortex HormonesAmbulatory Care FacilitiesAnti-Inflammatory Agents, Non-SteroidalAzathioprineCross-Sectional StudiesFemaleHumansHydroxychloroquineInfliximabMaleMethotrexateRetrospective StudiesAdrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalAzathioprineHydroxychloroquineInfliximabMethotrexateArthritisOrgan ınvolvementSarcoidosisUveitis

Identifiers

PMID36006458
OpenAlexW4293105562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.